On the evening of January 9, Chongqing Xishan Technology (688576), a leader in the medical device segment industry, announced that on January 9, the company repurchased 7,699 shares of the company for the first time through the Shanghai ** exchange trading system in a centralized bidding transaction, accounting for 0 percent of the company's total share capital0145%, the most ** repurchase is 8794 yuan shares, the lowest price is 8736 yuan shares, the total amount of funds paid is 67470,000 yuan (excluding transaction costs).
It is understood that on December 26, 2023, Xishan Technology launched a repurchase plan: it intends to use its own funds to repurchase shares through centralized bidding transactions on the Shanghai Stock Exchange within 12 months from now on, and the total amount of repurchase funds shall not be less than 0500 million yuan (inclusive), not more than 100 million yuan (inclusive), the ** of repurchased shares does not exceed 13580 yuan shares (inclusive), the repurchased shares are intended to be used for employee stock ownership plans or equity incentives at an appropriate time in the future.
On January 9, Winbond Health (002004) also announced that on January 8, the company implemented the first repurchase, repurchasing 870,000 shares through centralized bidding transactions, accounting for 004%, the lowest transaction price is 461 yuan shares, the highest transaction price is 464 yuan shares, the total amount paid for the repurchase is about 402RMB 380,000 (excluding transaction costs).
It is reported that on December 27, 2023, based on the confidence in the company's development prospects and the recognition of the company's value, in order to safeguard the interests of investors, enhance the confidence of public investors in the company, and effectively protect the legitimate rights and interests of all shareholders, combined with the company's operating conditions and financial status and other factors, the company's board of directors decided to use its own funds through the Shenzhen Stock Exchange trading system to repurchase part of the ** through centralized bidding transactions, and the total amount of repurchase funds shall not be less than 20 million yuan (inclusive), not exceeding 30 million yuan (inclusive), the repurchase price is not higher than 721 yuan shares, the repurchase period is 12 months, and the repurchased shares are intended to be used for equity incentive plans or employee stock ownership plans.
Xishan Technology and Winbond Health said that they will continue to implement the above-mentioned repurchase plan during the repurchase period according to market conditions, and fulfill their information disclosure obligations in a timely manner.
Upstream news reporter Liu Yong intern Yang Hongyun.